Mike Herdman

• Economic Evaluation
• Infectious Diseases
• Meningitis
• Pfizer
• Resource Allocation
• Vaccines

Meningococcal Vaccines: An International Comparison of Decision-Making Processes, Frameworks and Methodologies. Are Values Missing?

Read more

• Clinical Outcomes

Can We Really Compare and Aggregate PRO Data Between People and Settings? Implications for Multi-Country Clinical Trials and HTA

Read more

• Cancer
• Clinical Outcomes
• NICE
• Oncology
• Roche

Quality of Life in Long-term Cancer Survivors: Implications for Future Health Technology Assessments in Oncology

Read more

• Clinical Outcomes
• EuroQol
• NHS
• UK
• EQ-5D and PROMs

New Methods for Analysing the Distribution of EQ-5D Observations

Read more

• Clinical Outcomes
• External Publications
• EQ-5D and PROMs
• Health Technology Assessment…

Age and Utilities: Issues for HTA

Read more